RecruitingNCT06535503

Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction (STEMI) Patients With Cardiogenic Shock at Abu Dhabi City


Sponsor

Abu Dhabi Health Services Company

Enrollment

400 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age more than 18.
  • STEMI complicated by cardiogenic shock.
  • Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
  • Patient admitted between January 2019 to March 2024.

Exclusion Criteria5

  • Age less than 18.
  • Shock patient not related to Myocardial infarction.
  • NSTEMI-related cardiogenic shock.
  • Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
  • Patient not admitted between January 2019 to March 2024.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Sheikh Khalifa Medical City (SKMC)

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

Sheikh Shakhbout Medical City (SKMC)

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06535503


Related Trials